Digital neurotherapy (DNT) Treatment for Depression

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Depression+2 MoreDigital neurotherapy (DNT) Treatment - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether a digital neurotherapy can help relieve depression, improve cognition, and quality of life in cancer survivors.

Eligible Conditions
  • Depression
  • Quality of Life
  • Cognition

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

11 Primary · 0 Secondary · Reporting Duration: Baseline, 4 weeks, 8 weeks

Week 8
Change in California Verbal Learning Test-II
Change in Controlled Oral Word Association Test
Change in Flanker Task
Change in Functional Assessment of Cancer Therapy-General
Change in Hospital Anxiety and Depression Questionnaire
Change in List Sort Working Memory
Change in Logical Memory
Change in Mindful Attention Awareness Scale
Change in Multidimensional Executive Function Screening Test
Change in Patient Health Questionnaire-9
Change in Short-Form 36 Health Survey

Trial Safety

Trial Design

2 Treatment Groups

Wait list control group
1 of 2
Digital neurotherapy (DNT) Treatment
1 of 2

Active Control

Experimental Treatment

50 Total Participants · 2 Treatment Groups

Primary Treatment: Digital neurotherapy (DNT) Treatment · No Placebo Group · N/A

Digital neurotherapy (DNT) Treatment
Behavioral
Experimental Group · 1 Intervention: Digital neurotherapy (DNT) Treatment · Intervention Types: Behavioral
Wait list control group
Behavioral
ActiveComparator Group · 1 Intervention: Wait list control group · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 4 weeks, 8 weeks

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,680 Previous Clinical Trials
21,088,209 Total Patients Enrolled
52 Trials studying Depression
8,444 Patients Enrolled for Depression
Jennifer Kilkus, MDPrincipal InvestigatorYale University

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are willing to comply with all study procedures and are available for the duration of the study.
You have received chemotherapy, and/or radiation treatment, and/or immunotherapy treatment for cancer.
You are able to understand and read English.

Who else is applying?

What state do they live in?
Connecticut100.0%
How old are they?
18 - 65100.0%
What site did they apply to?
Yale New Haven Hospital100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%